It’s been just a year and a half since Pernix Therapeutics cut 23% of its sales force, but the company is downsizing once again. More: Pernix lays off another 41 sales staffers as Treximet generics loom Source: fierce
read moreWith all the commotion and fury from different directions targeting Sanofi’s Dengvaxia, the Philippines has now only suspended the vaccine’s approval and fined the drugmaker a symbolic $2,000. More: Philippines suspends Dengvaxia approval, fines Sanofi a symbolic ,000 Source: fierce
read moreTrailing in the wake of Pfizer’s Ibrance, Novartis’ Kisqali is one step closer to nabbing a regulatory boost. The FDA has granted the breast cancer fighter its breakthrough designation as a first-line treatment for premenopausal women with HR-positive, HER2-negative breast
read moreWith the New Year comes a new tax system in the U.S., and now many analysts and consultants are digging into how the GOP’s reform will affect major pharma players. This week, Leerink Partners analysts are out with their picks
read morePower has been restored to three Baxter International plants in Puerto Rico, meaning production of saline solution and amino acids is increasing. But that doesn’t mean the shortages that have plagued the entire U.S. healthcare system are past. More: Saline
read moreClinical Commissioning Groups in England are declaring just two-thirds of payments they have received from private companies and charities, an investigation led by the British Medical Journal has revealed. More: CCGs failing to disclose private/charity payments, finds BMJ Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals